A recent innovation from an EPFL laboratory will enable, for the first time, mass production of standardized organoids. This breakthrough was achieved thanks to a customized guidance system that ensures homogenous cell culturing. ...
Jun 8, 2020
0
160
Federally funded research contributed to the science underlying each of the 59 new cancer drugs approved by the FDA from 2010-2016 according to a study from Bentley University. The article, titled "NIH funding for research ...
Jun 2, 2020
0
0
A new trial to prevent organ failure and death in COVID-19 patients has been launched led by clinicians and scientists in Cambridge and London.
May 20, 2020
0
4
Researchers in the Ludwig Center at the Johns Hopkins Kimmel Cancer Center report they have identified a drug treatment that could—if given early enough—potentially reduce the risk of death from the most serious complication ...
May 19, 2020
0
33
Recent large-scale efforts to categorize the molecular data of multiple cancer types has yielded so much information that researchers now have a new question: How to turn all this data into meaningful information that guides ...
May 19, 2020
0
78
Scientists around the globe are working to identify approved and investigational drugs that can be repurposed to treat COVID-19.
May 13, 2020
0
3
In December 2019, the world learned of a new and deadly pathogen. News coming out of Wuhan, China confirmed public health experts' worst fears—a novel coronavirus appeared to have jumped from animals to humans. It was extremely ...
May 11, 2020
0
2
Scientists have used 3-D models to break down the DNA behavior of cancer cells, in a breakthrough new study which could revolutionize treatment for the disease.
May 11, 2020
0
43
U.S. regulators have approved a new type of coronavirus test that administration officials have promoted as a key to opening up the country.
May 9, 2020
1
54
U.S. regulators Monday pulled back a decision that allowed scores of coronavirus blood tests to hit the market without first providing proof that they worked.
May 4, 2020
0
1
